Jiangsu Recbio Technology Co., Ltd.

SEHK:2179 Stock Report

Market Cap: HK$4.0b

Jiangsu Recbio Technology Balance Sheet Health

Financial Health criteria checks 3/6

Jiangsu Recbio Technology has a total shareholder equity of CN¥835.8M and total debt of CN¥681.3M, which brings its debt-to-equity ratio to 81.5%. Its total assets and total liabilities are CN¥2.1B and CN¥1.2B respectively.

Key information

81.5%

Debt to equity ratio

CN¥681.32m

Debt

Interest coverage ration/a
CashCN¥531.30m
EquityCN¥835.76m
Total liabilitiesCN¥1.22b
Total assetsCN¥2.06b

Recent financial health updates

Recent updates

Jiangsu Recbio Technology (HKG:2179) Is Making Moderate Use Of Debt

Aug 23
Jiangsu Recbio Technology (HKG:2179) Is Making Moderate Use Of Debt

Does Jiangsu Recbio Technology (HKG:2179) Have A Healthy Balance Sheet?

Mar 26
Does Jiangsu Recbio Technology (HKG:2179) Have A Healthy Balance Sheet?

Financial Position Analysis

Short Term Liabilities: 2179's short term assets (CN¥795.4M) exceed its short term liabilities (CN¥681.6M).

Long Term Liabilities: 2179's short term assets (CN¥795.4M) exceed its long term liabilities (CN¥541.3M).


Debt to Equity History and Analysis

Debt Level: 2179's net debt to equity ratio (17.9%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if 2179's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 2179 has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: 2179 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 26.6% each year


Discover healthy companies